Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Investor's Business DailyGuardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant’s blood-based colon cancer screening test.
The post Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests appeared first on I…